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Background
CCL5 (Rantes) is a chemotactic cytokine playing an
active role in recruiting leukocytes into inflammatory
sites and known to attract Treg cells in solid tumors
where they inhibit immune responses.
Material, methods and results
In rat recipients of kidney allografts where tolerance was
induced by costimulation blockade, we observed a 2-fold
decrease of plasma CCL5 levels as compared to control
syngeneic grafted animals (0.60 ± 0.17 vs. 1.17 ± 0.48
ng/ml; p<0.01). Myeloid-derived suppressor cells
(MDSC), a major cell type producing CCL5 in blood,
also presented a reduced capacity to produce CCL5 in
these tolerant animals. In contrast, intragraft levels of
CCL5 mRNA and protein were higher in tolerated allo-
grafts, establishing an increased graft-to-periphery CCL5
gradient possibly contributing to the recruitment of Treg
cells into the graft, as in solid tumor, and leading to the
establishment and maintenance of tolerance. To test the
hypothesis, we broke the gradient by restoring normal
plasma concentrations of CCL5 by implantation of osmo-
tic pumps. This induced a strong reduction of intragraft
Treg cells (decrease of 24.40 ± 5.47 fold; p<0.05 by
immunohistofluorescence and of Foxp3 mRNA assessed
by qRT-PCR), and led to an increase of creatinine and
urea concentrations and eventually to kidney graft
rejection.
Conclusions
Our data uncover a novel role of CCL5, possibly con-
trolled by MDSC, in this rat model of kidney transplant
tolerance: a graft-to-periphery gradient of CCL5 help
recruiting Treg cells into the graft where they maintain
tolerance.
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